Haemonetics

$116.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.65 (-0.55%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Haemonetics and other stocks, options, and ETFs commission-free!

About HAE

Haemonetics Corporation, also called Haemonetics, is a global healthcare company, which engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate.

CEO
Christopher A. Simon
Employees
3,004
Headquarters
Boston, Massachusetts
Founded
1971
Market Cap
5.80B
Price-Earnings Ratio
55.22
Dividend Yield
—
Average Volume
503.69K
High Today
$119.71
Low Today
$116.81
Open Price
$119.09
Volume
130.70K
52 Week High
$142.11
52 Week Low
$74.48

HAE Earnings

$0.00
$0.31
$0.63
$0.94
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected May 4, Pre-Market

You May Also Like

FEP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure